Immuno-metabolism is well understood to influence many aspects of immune cell response as both an indicator and controller of immune cell fate, function, and fitness.
This concept is clearly illustrated in the metabolic ramping of naive T cells to proliferate following activation signalling, and distinct metabolic phenotypes that drive effector and memory function and T cell persistence.
The Agilent Seahorse XF Hu T Cell Activation Assay is an optimized turnkey solution that detects T cell activation in minutes, providing a kinetic readout of T cell activation dynamics in real-time. This delivers a unique, early window of T cell biology, enabling researchers to quantify activation kinetics and profile modulators of T cell behavior.
Glucose metabolism is recognized as a driver for T cell fate and function. A rapid increase in glycolysis is a signature early event during T cell activation and is required for subsequent T cell proliferation and differentiation. By measuring the increase in glycolysis as proton efflux rate (PER), Agilent Seahorse technology provides an early kinetic window to interrogate T cell activation.
Modulate T cells with integrated reagent injection ports. Monitor responses in real time.
Agilent Seahorse XF sensor cartridges incorporate integrated injection ports that sequentially deliver up to two reagents prior to the activator injection, allowing analysis of the acute effects of modulators on T cell activation.
Dive deeper with Seahorse XF cell metabolism assays to explore programs that drive T cell development and function, investigate metabolic poise and switches that are associated with T cell proliferation, differentiation and fitness, and gain new insights for immunotherapy discovery
Sponsored by: Cell Culture Dish
Duration: 26:37
Guests:
Dave Eansor
Bio-Techne
President, Protein Sciences Segment
Sean Kevlahan, Ph.D.
Bio-Techne
Senior Director, Cell and Gene Therapy
Featured products: